statements

Transchem Ltd.

BSE: 500422

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

310.00+8.0 (+2.65%)

7 Aug, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Transchem Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
EPS - Basic - ex Extraordinary Items	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Operating Revenue	1.53	-	-	-	1.02	1.02	0.97	0.80	-	-	-	-	0.41	2.61	0.01
EPS - Diluted - ex Extraordinary Items	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	-2.34	-2.73	-2.39	-1.97	-1.92	-2.00	-2.66	-1.98	-1.97	-2.06	-2.75	-1.74	-1.72	-1.47	-3.65
EBITDA	-0.81	-1.19	-0.87	-0.89	-0.90	-0.98	-1.69	-1.18	-1.39	-1.93	-2.74	-1.73	-1.71	-1.46	-3.64
EBITDA Margin	-	-	-	-	-	-	-	-	-	-	-	-	-418.0	-55.7	-
Supplementary
Financing Income/(Expense) - Net	1.95	2.20	1.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.00	0.01	0.04
Gross Profit	-1.53	-	-	-	-1.02	-1.02	-0.97	-0.80	-	-	-	-	0.00	0.02	-0.01
Gross Margin	-	-	-	-	-	-	-	-	-	-	-	-	0.5	0.6	-
Profit before Taxes	-3.81	-1.32	-0.77	0.12	0.05	-0.22	-0.55	0.78	0.79	24.77	3.91	2.50	5.65	7.06	5.61
Profit after Tax	-3.34	-1.32	-0.80	0.12	0.05	-0.22	-1.19	0.31	0.41	24.15	2.87	1.24	4.20	5.23	-
PAT Margin	-	-	-	-	-	-	-	-	-	-	-	-	1,025.2	198.7	-
Total Operating Expenses	2.34	2.73	2.39	1.97	1.92	2.00	2.66	1.98	1.97	2.06	2.75	1.74	2.13	4.10	3.65
Operating Profit	-2.34	-2.73	-2.39	-1.97	-1.92	-2.00	-2.66	-1.98	-1.97	-2.06	-2.75	-1.74	-1.72	-1.47	-3.65
Operating Margin	-	-	-	-	-	-	-	-	-	-	-	-	-419.9	-55.9	-
Income Taxes	-0.48	-	0.03	-	-	-	0.64	0.47	0.38	0.62	1.04	1.27	1.45	1.84	1.31
Total Revenue	-	-	-	-	-	-	-	-	-	-	-	-	0.41	2.63	-

Balance Sheet

Abridged

Understanding Balance Sheet

Transchem Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Assets	44.20	41.14	38.52	38.57	38.53	38.15	36.98	38.37	37.07	63.42	66.81	66.23	76.32	79.73	87.73
Total Shareholders' Equity	40.35	39.03	38.23	38.35	38.22	37.99	36.81	37.98	36.77	62.94	66.30	65.84	75.65	79.32	83.58
Total Current Liabilities	0.74	0.36	0.13	0.05	0.21	0.04	0.03	0.22	0.10	0.26	0.28	0.09	0.48	0.30	4.00
Accumulated Depreciation & Impairment	25.22	26.76	28.28	-	-	-	-	-	-	-	-	-	-	-	-
Long-Term Investments	2.03	2.03	2.03	2.03	2.03	2.03	2.03	5.93	3.69	8.69	8.82	8.23	8.91	2.04	1.97
Total Non-Current Liabilities	3.12	1.75	0.16	0.17	0.10	0.13	0.14	0.17	0.21	0.22	0.23	0.30	0.19	0.11	0.16
Long Term Debt	3.00	1.61	-	-	-	-	-	-	-	-	-	-	-	-	-
Property Plant & Equipment - Gross	37.72	37.74	37.75	-	-	-	-	-	-	-	-	-	-	-	-
Property Plant & Equipment - Net	12.50	10.99	9.47	8.40	7.42	6.40	5.43	4.27	3.70	0.11	0.10	0.09	0.08	0.05	0.02
Total Liabilities & Equity	44.20	41.14	38.52	38.57	38.53	38.15	36.98	38.37	37.07	63.42	66.81	66.23	76.32	79.73	87.73
Total Current Assets	28.85	27.30	26.19	27.32	28.26	29.08	29.52	28.17	29.68	54.63	57.90	57.90	67.33	77.64	85.48
Total Non-Current Assets	15.36	13.84	12.33	11.25	10.26	9.07	7.46	10.20	7.39	8.79	8.91	8.32	8.99	2.08	2.25
Total Liabilities	3.85	2.11	0.29	0.22	0.31	0.16	0.17	0.39	0.30	0.48	0.51	0.39	0.67	0.41	4.15
Total Equity	40.35	39.03	38.23	38.35	38.22	37.99	36.81	37.98	36.77	62.94	66.30	65.84	75.65	79.32	83.58

Cash Flow

Abridged

Understanding Cash Flow Statement

Transchem Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Capital Expenditures - Net	0.00	0.02	0.01	-	0.04	0.00	-	-0.18	-	-25.93	-	-	0.00	-0.53	-1.58
Capital Expenditures - Gross	0.00	0.02	0.01	-	0.04	0.00	-	0.00	-	0.08	-	-	0.00	0.00	0.02
Working Capital - Increase/(Decrease)	3.57	1.83	0.05	0.11	0.32	-0.16	-20.63	9.22	-1.35	-29.47	19.46	-0.21	-43.62	31.77	-5.05
Free Cash Flow to Equity	1.34	2.08	0.77	1.41	1.31	0.82	-19.59	10.63	-0.62	-1.79	21.93	-	-39.28	36.53	0.02
Free Operating CF	1.34	2.08	0.77	1.41	1.31	0.82	-19.59	10.44	-0.62	-27.80	21.93	1.24	-39.28	36.00	-1.58
Free Operating CF net dividend	1.34	2.08	0.77	1.41	1.31	0.82	-19.59	10.44	-0.62	-27.80	21.93	1.24	-39.28	36.00	-1.58
Operating CF bef Changes in Working Cap	-2.23	0.27	0.72	1.31	1.04	0.98	1.04	1.23	0.73	1.76	2.47	1.45	4.34	4.23	3.48
Net Cash Flow from Financing Activities	-	-1.39	-1.61	-	-	-	-	-	-	-	-	-	-	-	-
Net CF from Investing Activities	-1.80	-0.36	0.77	-1.57	-0.55	-1.77	19.58	5.62	0.66	23.05	0.58	-0.96	5.10	6.02	1.64
Net CF from Operating Activities	1.34	2.10	0.78	1.41	1.35	0.82	-19.59	10.44	-0.62	-27.71	21.93	1.24	-39.28	36.01	-1.55

Business Segment Analysis

Transchem Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Transchem Ltd.

Regional Segment Analysis

Transchem Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Transchem Ltd.

Historical Segment Analysis

Track how Transchem Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Transchem Ltd.

Frequently Asked Questions

What is the revenue of Transchem Ltd.?

The latest trailing twelve month revenue of Transchem Ltd. is ₹ 0.00 Cr. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Transchem Ltd.?

The latest trailing twelve month net profit (PAT) of Transchem Ltd. is ₹ 4.30 Cr, with a 3-year earnings CAGR of 51.44%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Transchem Ltd.?

The operating margin of Transchem Ltd. is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of Transchem Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Transchem Ltd. is 3.51. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Transchem Ltd.?

The debt-to-equity ratio of Transchem Ltd. stands at 0.00. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Transchem Ltd.?

The estimated book value per share of Transchem Ltd. is 68.28 (derived from a P/B ratio of 4.54 and market price of ₹ 310.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Transchem Ltd.?

The trailing twelve month operating cash flow of Transchem Ltd. is ₹ -1.55 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Transchem Ltd. report consolidated or standalone financials?

Transchem Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.